On Friday, Axonics Inc (AXNX) stock saw a decline, ending the day at $69.15 which represents a decrease of $-0.10 or -0.14% from the prior close of $69.25. The stock opened at $69.26 and touched a low ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a ...

12 ceremony. Axonics Inc. (Nasdaq: AXNX), a maker of medical devices to treat incontinence, said a jury has returned a ...

A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the ...

Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Buy AXNX near 68.15 target 71.79 stop loss @ 67.95 Details The technical summary data tells us to buy AXNX near 68.15 with an upside target of 71.79. This data also tells us to set a stop loss @ 67.95 ...

Teleflex has higher revenue and earnings than Axonics. Axonics is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks ...